Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases
Open Access
- 6 January 2010
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (4) , 1010-1023
- https://doi.org/10.1245/s10434-009-0887-5
Abstract
As the real clinical significance of carcinoembryonic antigen (CEA) and carbohydrate antigen 19.9 (CA19.9) evolution during preoperative chemotherapy for cKeywords
This publication has 28 references indexed in Scilit:
- Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal CancerJournal of Clinical Oncology, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal CancerAnnals of Surgical Oncology, 2006
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by ChemotherapyAnnals of Surgery, 2004
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] MetastasesAnnals of Surgical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Repeat Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 1997
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995